|
1
|
Funk CD: Prostaglandins and leukotrienes:
Advances in eico-sanoid biology. Science. 294:1871–1875. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hennig R, Osman T, Esposito I, Giese N,
Rao SM, Ding XZ, Tong WG, Buchler MW, Yokomizo T, Friess H and
Adrian TE: BLT2 is expressed in PanINs, IPMNs, pancreatic cancer
and stimulates tumour cell proliferation. Br J Cancer.
99:1064–1073. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim EY, Seo JM, Kim C, Lee JE, Lee KM and
Kim JH: BLT2 promotes the invasion and metastasis of aggressive
bladder cancer cells through a reactive oxygen species-linked
pathway. Free Radic Biol Med. 49:1072–1081. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Park J, Park SY and Kim JH: Leukotriene B4
receptor 2 contributes to chemoresistance of SK-OV-3 ovarian cancer
cells through activation of signal transducer and activator of
transcription-3-linked cascade. Biochim Biophys Acta. 1863:236–243.
2016. View Article : Google Scholar
|
|
5
|
Kim H, Choi JA, Park GS and Kim JH: BLT2
up-regulates interleukin-8 production and promotes the invasiveness
of breast cancer cells. PLoS One. 7:e491862012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Seo JM, Park S and Kim JH: Leukotriene B4
receptor 2 promotes invasiveness and metastasis of ovarian cancer
cells through signal transducer and activator of transcription 3
(STAT3)-dependent up-regulation of matrix metalloproteinase-2. J
Biol Chem. 287:13840–13849. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee JW and Kim JH: Activation of the
leukotriene B4 receptor 2-reactive oxygen species (BLT2-ROS)
cascade following detachment confers anoikis resistance in prostate
cancer cells. J Biol Chem. 288:30054–30063. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Harmey JH, Bucana CD, Lu W, Byrne AM,
McDonnell S, Lynch C, Bouchier-Hayes D and Dong Z:
Lipopolysaccharide-induced metastatic growth is associated with
increased angiogenesis, vascular permeability and tumor cell
invasion. Int J Cancer. 101:415–422. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Szajnik M, Szczepanski MJ, Czystowska M,
Elishaev E, Mandapathil M, Nowak-Markwitz E, Spaczynski M and
Whiteside TL: TLR4 signaling induced by lipopolysaccharide or
paclitaxel regulates tumor survival and chemoresistance in ovarian
cancer. Oncogene. 28:4353–4363. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen X, Zhao F, Zhang H, Zhu Y, Wu K and
Tan G: Significance of TLR4/MyD88 expression in breast cancer. Int
J Clin Exp Pathol. 8:7034–7039. 2015.PubMed/NCBI
|
|
11
|
Yang H, Wang B, Wang T, Xu L, He C, Wen H,
Yan J, Su H and Zhu X: Toll-like receptor 4 prompts human breast
cancer cells invasiveness via lipopolysaccharide stimulation and is
over-expressed in patients with lymph node metastasis. PLoS One.
9:e1099802014. View Article : Google Scholar
|
|
12
|
Ahmed A, Wang JH and Redmond HP: Silencing
of TLR4 increases tumor progression and lung metastasis in a murine
model of breast cancer. Ann Surg Oncol. 20(Suppl 3): S389–S396.
2013. View Article : Google Scholar
|
|
13
|
Park GS and Kim JH: Myeloid
differentiation primary response gene 88-leukotriene B4 receptor 2
cascade mediates lipopoly-saccharide-potentiated invasiveness of
breast cancer cells. Oncotarget. 6:5749–5759. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li HB and Chen F: Isolation and
purification of baicalein, wogonin and oroxylin A from the
medicinal plant Scutellaria baicalensis by high-speed
counter-current chromatography. J Chromatogr A. 1074:107–110. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brekhman II, Grinevitch MA and Kyu KB:
Oriental medicine: A computerized study of complex recipes and
their components: Herbs most frequently used in traditional
Japanese and Korean medicine. Am J Chin Med. 9:134–143. 1981.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo Q, Zhao L, You Q, Yang Y, Gu H, Song
G, Lu N and Xin J: Anti-hepatitis B virus activity of wogonin in
vitro and in vivo. Antiviral Res. 74:16–24. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Khan NM, Haseeb A, Ansari MY, Devarapalli
P, Haynie S and Haqqi TM: Wogonin, a plant derived small molecule,
exerts potent anti-inflammatory and chondroprotective effects
through the activation of ROS/ERK/Nrf2 signaling pathways in human
Osteoarthritis chondrocytes. Free Radic Biol Med. 106:288–301.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu Y, Yang B, Hu Y, Lu L, Lu X, Wang J, Xu
F, Yu S, Huang J and Liang X: Wogonin prevents
TLR4-NF-kappaB-medicated neuro-inflammation and improves retinal
ganglion cells survival in retina after optic nerve crush.
Oncotarget. 7:72503–72517. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huynh DL, Sharma N, Kumar Singh A, Singh
Sodhi S, Zhang JJ, Mongre RK, Ghosh M, Kim N, Ho Park Y and Kee
Jeong D: Anti-tumor activity of wogonin, an extract from
Scutellaria baicalensis, through regulating different signaling
pathways. Chin J Nat Med. 15:15–40. 2017.PubMed/NCBI
|
|
20
|
Huang KF, Zhang GD, Huang YQ and Diao Y:
Wogonin induces apoptosis and down-regulates survivin in human
breast cancer MCF-7 cells by modulating PI3K-AKT pathway. Int
Immunopharmacol. 12:334–341. 2012. View Article : Google Scholar
|
|
21
|
Lin CM, Chen YH, Ong JR, Ma HP, Shyu KG
and Bai KJ: Functional role of wogonin in anti-angiogenesis. Am J
Chin Med. 40:415–427. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang H, Hui H, Wang Q, Li H, Zhao K, Zhou
Y, Zhu Y, Wang X, You Q, Guo Q and Lu N: Wogonin induces cell cycle
arrest and erythroid differentiation in imatinib-resistant K562
cells and primary CML cells. Oncotarget. 5:8188–8201. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma X, Xie KP, Shang F, Huo HN, Wang LM and
Xie MJ: Wogonin inhibits IGF-1-stimulated cell growth and estrogen
receptor alpha expression in breast adenocarcinoma cell and
angiogenesis of chick chorioallantoic membrane. Sheng Li Xue Bao.
64:207–212. 2012.PubMed/NCBI
|
|
24
|
Chen P, Lu N, Ling Y, Chen Y, Hui H, Lu Z,
Song X, Li Z, You Q and Guo Q: Inhibitory effects of wogonin on the
invasion of human breast carcinoma cells by downregulating the
expression and activity of matrix metalloproteinase-9. Toxicology.
282:122–128. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hou L, Chen L and Fang L: Scutellarin
inhibits proliferation, invasion, and tumorigenicity in human
breast cancer cells by regulating HIPPO-YAP signaling pathway. Med
Sci Monit. 23:5130–5138. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Harrison LJ, Sia GL and Sim KY:
5,7-Dihydroxy-8-methoxyflavone from Tetracera indica. Planta Med.
60:493–494. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Choi JA, Lee JW, Kim H, Kim EY, Seo JM, Ko
J and Kim JH: Pro-survival of estrogen receptor-negative breast
cancer cells is regulated by a BLT2-reactive oxygen species-linked
signaling pathway. Carcinogenesis. 31:543–551. 2010. View Article : Google Scholar
|
|
28
|
Mehner C, Hockla A, Miller E, Ran S,
Radisky DC and Radisky ES: Tumor cell-produced matrix
metalloproteinase-9 (MMP-9) drives malignant progression and
metastasis of basal-like triple negative breast cancer. Oncotarget.
5:2736–2749. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim EY, Seo JM, Cho KJ and Kim JH:
Ras-induced invasion and metastasis are regulated by a leukotriene
B4 receptor BLT2-linked pathway. Oncogene. 29:1167–1178. 2010.
View Article : Google Scholar
|
|
30
|
Park GS and Kim JH: LPS up-regulates
ICAM-1 expression in breast cancer cells by stimulating a
MyD88-BLT2-ERK-linked cascade, which promotes adhesion to
monocytes. Mol Cells. 38:821–828. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Truong D, Puleo J, Llave A, Mouneimne G,
Kamm RD and Nikkhah M: Breast cancer cell invasion into a three
dimensional tumorstroma microenvironment. Sci Rep. 6:340942016.
View Article : Google Scholar
|
|
32
|
Jemal A, Ward E and Thun MJ: Recent trends
in breast cancer incidence rates by age and tumor characteristics
among U.S. women. Breast Cancer Res. 9:R282007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huynh DL, Kwon T, Zhang JJ, Sharma N, Gera
M, Ghosh M, Kim N, Kim Cho S, Lee DS, Park YH and Jeong DK: Wogonin
suppresses stem cell-like traits of CD133 positive osteosarcoma
cell via inhibiting matrix metalloproteinase-9 expression. BMC
Complement Altern Med. 17:3042017. View Article : Google Scholar
|
|
34
|
Liu X, Tian S, Liu M, Jian L and Zhao L:
Wogonin inhibits the proliferation and invasion, and induces the
apoptosis of HepG2 and Bel7402 HCC cells through NF-kappaB/Bcl-2,
EGFR and EGFR downstream ERK/AKT signaling. Int J Mol Med.
38:1250–1256. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhao K, Wei L, Hui H, Dai Q, You QD, Guo
QL and Lu N: Wogonin suppresses melanoma cell B16-F10 invasion and
migration by inhibiting Ras-medicated pathways. PLoS One.
9:e1064582014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lim BO: Effects of wogonin, wogonoside,
and 3,5,7,2′,6′-penta hydroxyflavone on chemical mediator
production in peritoneal exduate cells and immunoglobulin E of rat
mesenteric lymph node lymphocytes. J Ethnopharmacol. 84:23–29.
2003. View Article : Google Scholar
|
|
37
|
Zeng H, Dou S, Zhao J, Fan S, Yuan X, Zhu
S, Li L, Zhang W and Liu R: The inhibitory activities of the
components of Huang-Lian-Jie-Du-Tang (HLJDT) on eicosanoid
generation via lipoxygenase pathway. J Ethnopharmacol. 135:561–568.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang L, Ling Y, Chen Y, Li CL, Feng F, You
QD, Lu N and Guo QL: Flavonoid baicalein suppresses adhesion,
migration and invasion of MDA-MB-231 human breast cancer cells.
Cancer Lett. 297:42–48. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ma X, Yan W, Dai Z, Gao X, Ma Y, Xu Q,
Jiang J and Zhang S: Baicalein suppresses metastasis of breast
cancer cells by inhibiting EMT via downregulation of SATB1 and
Wnt/β-catenin pathway. Drug Des Devel Ther. 10:1419–1441. 2016.
View Article : Google Scholar :
|
|
40
|
Peters-Golden M and Henderson WR Jr:
Leukotrienes. N Engl J Med. 357:1841–1854. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gautam S, Roy S, Ansari MN, Saeedan AS,
Saraf SA and Kaithwas G: DuCLOX-2/5 inhibition: A promising target
for cancer chemoprevention. Breast Cancer. 24:180–190. 2017.
View Article : Google Scholar
|
|
42
|
Green AR, Green VL, White MC and Speirs V:
Expression of cytokine messenger RNA in normal and neoplastic human
breast tissue: Identification of interleukin-8 as a potential
regulatory factor in breast tumours. Int J Cancer. 72:937–941.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Merdad A, Karim S, Schulten HJ, Dallol A,
Buhmeida A, Al-Thubaity F, Gari MA, Chaudhary AG, Abuzenadah AM and
Al-Qahtani MH: Expression of matrix metalloproteinases (MMPs) in
primary human breast cancer: MMP-9 as a potential biomarker for
cancer invasion and metastasis. Anticancer Res. 34:1355–1366.
2014.PubMed/NCBI
|
|
44
|
Wang W, Xia T and Yu X: Wogonin suppresses
inflammatory response and maintains intestinal barrier function via
TLR4-MyD88-TAK1-mediated NF-kappaB pathway in vitro. Inflamm Res.
64:423–431. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Karroum A, Mirshahi P, Benabbou N, Faussat
AM, Soria J, Therwath A, Mirshahi M and Hatmi M: Matrix
metallo-proteinase-9 is required for tubular network formation and
migration of resistant breast cancer cells MCF-7 through PKC and
ERK1/2 signalling pathways. Cancer Lett. 295:242–251. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kim S, Jeon M, Lee JE and Nam SJ: MEK
activity controls IL-8 expression in tamoxifen-resistant MCF-7
breast cancer cells. Oncol Rep. 35:2398–2404. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jung YS and Lee SO: Apomorphine suppresses
TNF-α-induced MMP-9 expression and cell invasion through inhibition
of ERK/AP-1 signaling pathway in MCF-7 cells. Biochem Biophys Res
Commun. 487:903–909. 2017. View Article : Google Scholar : PubMed/NCBI
|
